Vivo Bio Tech Limited (BOM:511509)

India flag India · Delayed Price · Currency is INR
27.83
+0.57 (2.09%)
At close: Apr 29, 2026
-29.11%
Market Cap 617.57M
Revenue (ttm) 514.24M
Net Income (ttm) 45.17M
Shares Out 22.19M
EPS (ttm) 2.34
PE Ratio 11.91
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,016
Average Volume 21,316
Open 27.18
Previous Close 27.26
Day's Range 27.18 - 28.76
52-Week Range 20.35 - 43.35
Beta 0.18
RSI 52.21
Earnings Date May 19, 2026

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory... [Read more]

Industry Commercial Physical and Biological Research
Founded 1987
Employees 174
Stock Exchange Bombay Stock Exchange
Ticker Symbol 511509
Full Company Profile

Financial Performance

In fiscal year 2025, Vivo Bio Tech's revenue was 466.73 million, an increase of 2.69% compared to the previous year's 454.51 million. Earnings were 72.83 million, an increase of 188.27%.

Financial Statements

News

There is no news available yet.